Bausch Health Companies Inc. (BHC)
NYSE: BHC · IEX Real-Time Price · USD
8.75
-0.01 (-0.11%)
At close: May 1, 2024, 4:00 PM
9.48
+0.73 (8.34%)
After-hours: May 1, 2024, 7:57 PM EDT
Bausch Health Companies Employees
Bausch Health Companies had 20,270 employees on December 31, 2023. The number of employees increased by 370 or 1.86% compared to the previous year.
Employees
20,270
Change (1Y)
370
Growth (1Y)
1.86%
Revenue / Employee
$432,018
Profits / Employee
-$29,206
Market Cap
3.20B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 20,270 | 370 | 1.86% |
Dec 31, 2022 | 19,900 | 300 | 1.53% |
Dec 31, 2021 | 19,600 | -2,000 | -9.26% |
Dec 31, 2020 | 21,600 | -100 | -0.46% |
Dec 31, 2019 | 21,700 | 600 | 2.84% |
Dec 31, 2018 | 21,100 | 400 | 1.93% |
Dec 31, 2017 | 20,700 | -800 | -3.72% |
Dec 31, 2016 | 21,500 | -500 | -2.27% |
Dec 31, 2015 | 22,000 | 5,200 | 30.95% |
Dec 31, 2014 | 16,800 | -400 | -2.33% |
Dec 31, 2013 | 17,200 | 10,200 | 145.71% |
Dec 31, 2012 | 7,000 | 100 | 1.45% |
Dec 31, 2011 | 6,900 | 2,600 | 60.47% |
Dec 31, 2010 | 4,300 | 3,009 | 233.08% |
Dec 31, 2009 | 1,291 | -77 | -5.63% |
Dec 31, 2008 | 1,368 | -165 | -10.76% |
Dec 31, 2007 | 1,533 | -201 | -11.59% |
Dec 31, 2006 | 1,734 | -10 | -0.57% |
Dec 31, 2005 | 1,744 | -547 | -23.88% |
Dec 31, 2004 | 2,291 | 333 | 17.01% |
Dec 31, 2003 | 1,958 | 101 | 5.44% |
Dec 31, 2002 | 1,857 | 535 | 40.47% |
Dec 31, 2001 | 1,322 | 122 | 10.17% |
Dec 31, 2000 | 1,200 | 497 | 70.70% |
Feb 28, 1999 | 703 | 238 | 51.18% |
Dec 31, 1998 | 465 | 164 | 54.49% |
Jan 1, 1997 | 301 | 6 | 2.03% |
Jun 10, 1996 | 295 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Fortrea Holdings | 19,000 |
Evolent Health | 4,700 |
Sotera Health Company | 3,000 |
iRhythm Technologies | 2,000 |
HUTCHMED (China) | 1,988 |
TransMedics Group | 584 |
Progyny | 566 |
Iovance Biotherapeutics | 557 |
BHC News
- 20 days ago - Bausch Health to Announce First-Quarter 2024 Results on May 2 - Accesswire
- 20 days ago - Bausch wins US appeal to block Alvogen generic of diarrhea drug - Reuters
- 20 days ago - Court of Appeals for the Federal Circuit Issues Ruling in Norwich Case that Prevents FDA Approval of Norwich's Abbreviated New Drug Application Until 2029 - Accesswire
- 20 days ago - Acne Vulgaris Treatment PrARAZLO(TM) (Tazarotene Lotion, 0.045%) Now Available to Patients Through British Columbia PharmaCare Public Drug Plan - Accesswire
- 26 days ago - Bausch Health Announces Patent Lawsuit Against Amneal Pharmaceuticals - Accesswire
- 4 weeks ago - Bausch Health, Canada Inc. Announces First Public Drug Plan Listings for (Pr)UCERIS(R) (budesonide) Aerosol Foam to Help Address the Unmet Need for the Treatment of Mild to Moderate Distal Ulcerative Colitis in Adults - Accesswire
- 4 weeks ago - Based on a New Survey, More Than Half of Surveyed IBS/CIC Patients Feel Alone in Their Experience but Also Find That Social Media Helps Create a Community and Inspires Healthcare Provider Conversations - Accesswire
- 5 weeks ago - Bausch + Lomb Will Present New Scientific Data and Analyses at the American Society of Cataract and Refractive Surgery Annual Meeting - Business Wire